plasma
-
not specified
RT-qPCR; Clinical Sample Validation; ROC Analysis
CircSMARCA5 showed diagnostic value for early HCC (AUC 0.91 at cut-off 4.55; specificity 83.8%; sensitivity 91.7%) and may be a more sensitive predictor than AFP.
CircSMARCA5 is significantly down-regulated in plasma from HCC patients compared with HCV cirrhotic patients and controls. Plasma CircSMARCA5 shows strong diagnostic performance for early HCC and may outperform AFP in sensitivity.
0.4187
Evaluation of Circular RNA SMARCA5 as a Novel Biomarker for Hepatocellular Carcinoma.
clinical study